Solid Biosciences downgraded to Market Perform from Outperform at SVB Leerink. SVB Leerink analyst Joseph Schwartz downgraded Solid Biosciences to Market Perform and cut his price target for the shares to $8 from $50.
https://thefly.com/landingPageNews.php?id=2861437
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.